GenEp
Latest round
- Seed
Last raised
- Oct 2021
Total raised
- $1.4M
Investors
- 6
About GenEp
Based in Virginia, US, and founded in 2021 by CEO Andrew Krouse, GenEp, Inc. operates as a pre-clinical stage biotechnology company focuses on creating therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies. In October 2021, GenEp, Inc. GenEp, Inc.2 gain of function mutations drive uncontrolled seizures and are used in treatment resistance in certain rare genetic epilepsies and other treatment resistant epilepsies. The company offers mouse audiogenic reflex seizure model solutions for human SCN8A epileptic encephalopathy.
Who invested in GenEp
6 investors across 1 round
See all investors in GenEp
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 26, 2021
Amount
$1.4M
Investors
Questions about GenEp
Who invested in GenEp?
GenEp has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GenEp raised?
GenEp has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GenEp last raise money?
GenEp's most recent round on record is a Seed, in Oct 2021.
What does GenEp do?
Based in Virginia, US, and founded in 2021 by CEO Andrew Krouse, GenEp, Inc.
Where is GenEp headquartered?
GenEp is headquartered in Charlottesville, US.
Which VCs invest in companies like GenEp?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at GenEp's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like GenEp? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.